the New England Journal of Medicine,12
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Doctors thought this kidney drug helped some patients. It may help millions more.
Doctors thought this kidney drug helped some patients. It may help millions more. - Date: - June 8, 2026
Pancreatic cancer: New drug results prompt standing ovation at oncology conference
A new drug for advanced pancreatic cancer is being hailed as a major breakthrough after trial results showed that it almost doubles survival time in patients previously treated with chemotherapy. Phase 3 trial results for daraxonrasib, a once daily oral treatment, have been described as a potential “revolution” in treating pancreatic cancer, which has the lowest survival of all common cancers, with five year survival less than 7%.In the RASolute 302 trial of 500 patients with metastatic...
Leap in DNA synthesis slashes time to build new genetic sequences
A new method for writing DNA promises to unlock the potential of generative AI in biology, giving scientists a fast, affordable, and accurate way to physically build the novel genetic sequences that predictive models are now producing faster than anyone can construct them. The technique, called Sidewinder, can assemble dozens of genetic sequences simultaneously in a single test tube, producing just one incorrect junction for every 10 million assembly events—a level of precision that far...
UK media fails to disclose defence sector links in nearly 60% of cases
Executive summary This report reveals how retired senior British military figures are frequently presented in the UK media as purely independent experts on defence and security matters without mention of their personal commercial and employment interests in the defence, technology, intelligence, and security sectors in those reports. By analysing media reports between 2015 and May 2026, AOAV identified a repeated pattern where almost 60% of former key military personnel with links to the...